Search by Drug Name or NDC
NDC 62559-0530-01 Propranolol Hydrochloride 60 mg/1 Details
Propranolol Hydrochloride 60 mg/1
Propranolol Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is PROPRANOLOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Propranolol is used to treat high blood pressure, irregular heart rhythms, pheochromocytoma (tumor on a small gland near the kidneys), certain types of tremor, and hypertrophic subaortic stenosis (a heart muscle disease). It is also used to prevent angina (chest pain), migraine headaches, and to improve survival after a heart attack. Propranolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 62559-0530-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Propranolol (Cardiovascular)
Product Information
| NDC | 62559-0530 |
|---|---|
| Product ID | 62559-530_bd2b823e-3b57-46fa-869a-b648ae4d87d0 |
| Associated GPIs | 33100040107025 |
| GCN Sequence Number | 005115 |
| GCN Sequence Number Description | propranolol HCl CAP SA 24H 60 MG ORAL |
| HIC3 | J7C |
| HIC3 Description | BETA-ADRENERGIC BLOCKING AGENTS |
| GCN | 03233 |
| HICL Sequence Number | 002101 |
| HICL Sequence Number Description | PROPRANOLOL HCL |
| Brand/Generic | Generic |
| Proprietary Name | Propranolol Hydrochloride |
| Proprietary Name Suffix | ER |
| Non-Proprietary Name | propranolol hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 60 |
| Active Ingredient Units | mg/1 |
| Substance Name | PROPRANOLOL HYDROCHLORIDE |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA018553 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62559-0530-01 (62559053001)
| NDC Package Code | 62559-530-01 |
|---|---|
| Billing NDC | 62559053001 |
| Package | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-530-01) |
| Marketing Start Date | 2017-12-21 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.19014 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | PROPRANOLOL ER 60 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |